ImmunoGen Announces Acceptance of Biologics License Application for Mirvetuximab Soravtansine in Ovarian Cancer by US Food and Drug Administration with Priority Review Waltham, Business
Ardelyx Announces Additional Data Supporting the Efficacy and Safety of First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at DDW 2022 Waltham, Business
Big 5G Event 2022: Netcracker Discusses Technology Innovations and New Business Models Across the 5G Landscape Waltham, Business
GelSight Expands Global Reach in Target Markets Through New Distribution Partnerships Waltham, Business
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants Waltham, Business
Strategic Alignment Between Commercial and Medical Affairs Teams Is Critical to 'Compliant Coordination' Success Waltham, Business
Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR Annual Meeting Waltham, Business
Palleon Presents Preclinical Data on Lead Program E-602 and Novel Bifunctional PD-L1-Targeted Sialidase Waltham, Business
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System Waltham, Business
Telenet Upgrades to Netcracker Online Charging System in Ongoing Digital Transformation Program Waltham, Business
ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer Waltham, Business
ImmunoGen Presents Full Results from Positive Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at SGO Annual Meeting Waltham, Business